EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Systematic Review of Participation, Positivity, and Yield Over Time in Fecal Immunochemical Test-Based Organized Colorectal Cancer Screening Programs

Sandra Baile-Maxía, Michael Pimienta, Carmen Sánchez-Ardila, Antoni Castells, Rodrigo Jover, Uri Ladabaum

Clinical Gastroenterology and Hepatology · 2026-08 · 24 (8) · 2094-2107

DOI: 10.1016/j.cgh.2026.02.009 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-08. Verfasst von Sandra Baile-Maxía und 5 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Medicina Digestiva, Hospital General Universitario Dr Balmis, Instituto de Investigación Biomédica Instituto de Investigación Sanitaria y…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Early Detection of Cancer, Feces, Mass Screening. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Instituto de Investigación Sanitaria y Biomédica de Alicante.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Fecal immunochemical testing (FIT), the most common colorectal cancer (CRC) screening modality worldwide, requires programmatic participation over decades. We performed a systematic review and meta-analysis to ascertain overall adherence patterns, per-round participation, FIT positivity, and neoplasia detection rates in organized FIT-based screening programs, contrasting initial vs subsequent screening rounds. METHODS: We systematically searched the PubMed, Embase, and Cochrane databases. Adherence patterns were defined as consistent screeners (all rounds), intermittent screeners, and never attendants. Per-round participation, FIT positivity, and positive predictive values (PPVs) for CRC, advanced adenoma (AA), and adenoma were determined overall and for consistent screeners. Subgroup analyses were performed by screening periodicity and FIT positivity cutoff. RESULTS: Of 4414 candidate studies, 24 were included. Adherence patterns were: 47.1% (standard deviation [SD], 11.6%) consistent screeners, 22.7% (SD, 4.7%) intermittent screeners, and 30.3% (SD, 12.2%) never attendants. Overall pooled results from the first through fourth rounds showed per-round participation of 51.3% (95% confidence interval [CI], 37.4%-65.3%); 56.7% (95% CI, 41.3%-72.2%), 56.9% (95% CI, 38.7%-75.3%), and 56.5% (95% CI, 44%-68.6%); FIT positivity of 6.6% (95% CI, 5.9%-7.3%), 5.6% (95% CI, 4.6%-6.6%), 5.3% (95% CI, 4.0%-6.6%), and 5.3% (3.7%-6.9%); CRC PPV of 5.8% (95% CI, 4.1%-7.4%), 3.3% (95% CI, 2.3%-4.3%), 2.9% (95% CI, 2.2%-3.7%), and 2.5% (95% CI, 1.4%-3.5%); AA PPV of 32.8% (95% CI, 23.5%-42.0%), 28.3% (95% CI, 21.8%-34.7%), 22.7% (95% CI, 16.5%-28.9%), and 23% (95% CI, 10.1%-35.9%); and adenoma PPV of 48.6% (95% CI, 45.8%-51.4%), 46.2% (95% CI, 42.4%-50.1%), 48.7% (95% CI, 43.9%-53.6%), and 44.6% (95% CI, 38.2%-51.0%), respectively. Similar trends were observed for consistent screeners and for biennial FIT with 20 μg Hb/g feces positivity cutoff. CONCLUSIONS: Organized FIT-based CRC screening programs achieve consistent participation in nearly one-half of persons and no participation in approximately one-third. FIT-positivity and yields for CRC, AA, and adenoma are highest in the first round and may stabilize at clinically relevant steady states at the third to fourth rounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsEarly Detection of CancerFecesMass ScreeningHumansImmunochemistry

Stichwörter der Autor:innen

AdherenceColorectal CancerFecal Immunochemical TestParticipationScreeningUptake

Autor:innen und Institutionen

  • Servicio de Medicina Digestiva, Hospital General Universitario Dr Balmis, Instituto de Investigación Biomédica Instituto de Investigación Sanitaria y Biomédica de Alicante, Centro de Investigación Biomédica en Red en el…
  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California; Department of Medicine, Stanford University School of Medicine, Stanford, California.
  • Facultad de Medicina, Universidad Miguel Hernández, Alicante, Spain.
  • Department of Gastroenterology, Hospital Clínic of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas, University of Barc…
  • Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California; Department of Medicine, Stanford University School of Medicine, Stanford, California. Electronic address: uri.la…

Förderung

  • Instituto de Salud Carlos III
  • Instituto de Investigación Sanitaria y Biomédica de Alicante

Zitieren

APA

Baile-Maxía, S., Pimienta, M., Sánchez-Ardila, C., Castells, A., Jover, R., & Ladabaum, U. (2026). Systematic Review of Participation, Positivity, and Yield Over Time in Fecal Immunochemical Test-Based Organized Colorectal Cancer Screening Programs. Clinical Gastroenterology and Hepatology, 24(8), 2094-2107. https://doi.org/10.1016/j.cgh.2026.02.009

Vancouver

Baile-Maxía S, Pimienta M, Sánchez-Ardila C, Castells A, Jover R, Ladabaum U. Systematic Review of Participation, Positivity, and Yield Over Time in Fecal Immunochemical Test-Based Organized Colorectal Cancer Screening Programs. Clinical Gastroenterology and Hepatology. 2026;24(8):2094-2107. doi:10.1016/j.cgh.2026.02.009

BibTeX
@article{BaileMaxa2026,
  author = {Baile-Maxía, Sandra and Pimienta, Michael and Sánchez-Ardila, Carmen and Castells, Antoni and Jover, Rodrigo and Ladabaum, Uri},
  title = {Systematic Review of Participation, Positivity, and Yield Over Time in Fecal Immunochemical Test-Based Organized Colorectal Cancer Screening Programs},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {8},
  pages = {2094--2107},
  doi = {10.1016/j.cgh.2026.02.009}
}
Kostenlos starten →